Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H13ClN2O |
Molecular Weight | 308.762 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C2N(CC#C)C(=O)CN=C(C3=CC=CC=C3)C2=C1
InChI
InChIKey=MFZOSKPPVCIFMT-UHFFFAOYSA-N
InChI=1S/C18H13ClN2O/c1-2-10-21-16-9-8-14(19)11-15(16)18(20-12-17(21)22)13-6-4-3-5-7-13/h1,3-9,11H,10,12H2
Pinazepam, a benzodiazepine derivative, differs from other drugs of its class by the presence of an unsaturated bond, the propargyl group, at the N-1 position. In animals, pinazepam controls anxiety and aggressiveness and exerts anticonvulsant activity. In clinical trials with open or controlled design, pinazepam, compared with diazepam, showed significant and purely anxiolytic action in patients suffering from anxiety with or without somatic manifestations, particularly in gastrointestinal disorders. Even though it is not a specific hypnotic drug, it seems to help patients in whom the physiological course of the sleep is disturbed. Pinazepam is used in the treatment of anxiety and insomnia associated with anxiety.
CNS Activity
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N05BA14
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
||
|
DEA NO. |
2883
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
||
|
WHO-VATC |
QN05BA14
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID3023475
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
m8823
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | Merck Index | ||
|
2175
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
100000081958
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
3708
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
DB13335
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
5286RBZ882
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
CHEMBL1213352
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
257-934-9
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
PINAZEPAM
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
52463-83-9
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
C66388
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
SUB09852MIG
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY | |||
|
40391
Created by
admin on Mon Mar 31 18:02:41 GMT 2025 , Edited by admin on Mon Mar 31 18:02:41 GMT 2025
|
PRIMARY |
ACTIVE MOIETY